Anaplastic large cell lymphoma: pathological, molecular and clinical features.
about
Brentuximab vedotin: treatment role for relapsed refractory systemic anaplastic large-cell lymphoma.Spectrum of CD30+ lymphoid proliferations in the eyelid lymphomatoid papulosis, cutaneous anaplastic large cell lymphoma, and anaplastic large cell lymphoma.ALK-driven tumors and targeted therapy: focus on crizotinibFusion tyrosine kinase NPM-ALK Deregulates MSH2 and suppresses DNA mismatch repair function novel insights into a potent oncoproteinAutologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.Simultaneous cytomorphological and multiparameter flow cytometric analysis of ALK-positive anaplastic large cell lymphoma in children.Predicting the outcome in non-Hodgkin lymphoma with molecular markers.Anaplastic large cell lymphoma with primary involvement of skeletal muscle: a rare case report and review of the literature.Role of nucleophosmin in acute myeloid leukemia.Pyrimidine tract-binding protein 1 mediates pyruvate kinase M2-dependent phosphorylation of signal transducer and activator of transcription 3 and oncogenesis in anaplastic large cell lymphoma.Therapeutic Potential of Resveratrol in Lymphoid Malignancies.Pathobiology of ALK-negative anaplastic large cell lymphoma.Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas.Establishment of a novel anaplastic large-cell lymphoma-cell line (COST) from a 'small-cell variant' of ALCL.Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells.A crucial role for the Anaplastic lymphoma kinase receptor tyrosine kinase in gut development in Drosophila melanogasterSmall cell variant of anaplastic large cell lymphoma with leukemic presentation: a diagnostic challenge.Pathobiology of anaplastic large cell lymphoma.5'-(RACE) identification of rare ALK fusion partner in anaplastic large cell lymphoma.Malignant hematopoietic cell lines: in vitro models for the study of anaplastic large-cell lymphoma.How do we define Hodgkin's disease? The authors' reply.Transmission of anaplastic large cell lymphoma via organ donation after cardiac death.Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion.High-dose therapy and autologous stem cell transplant does not result in long-term disease-free survival in patients with recurrent chemotherapy-sensitive ALK-negative anaplastic large-cell lymphoma.
P2860
Q33410081-67AD647D-2F7D-4B9C-9948-ABF96FF4BD70Q33697589-3B81DC6B-B935-4768-A5E6-53B85D8EED60Q34414378-CE779362-9E4F-4B9A-8510-F2CD8EA02D68Q35069957-1FCD12A3-236C-47E4-A580-33E0AC1D44DDQ35608203-E27502CF-B952-42A4-840C-378FEC45EA19Q36611784-9CC1DDA7-200B-4BBC-887B-0701CB818F0EQ36780164-0C61536E-1897-4EFF-BF3E-CE0D875B4CA0Q37453264-4323C1E1-EDD3-40DA-BA7E-EB49998C13CEQ37598941-CE9CED1D-E3D3-49EC-8CA0-E29AD4137C7AQ38707447-E35E1D86-2163-491E-B15A-88C770C71C79Q38793825-9C70B120-C887-4762-98B9-3B6400D0AD04Q38912284-DA3B87B5-CACD-4505-B8D9-726E1B346C93Q40052800-B0E6AE72-C069-4CAB-B2DF-663C6334A3BAQ40517540-11981FA9-2FFB-4D94-A49B-4F675C9DD478Q40543147-58931623-08AF-41B6-A8DE-0F71F569E733Q41008377-442C9629-990A-4E3A-9771-52250522D613Q41500327-6CF2403A-6A14-484A-AB64-305CDCEC8140Q41852473-ECFE2D55-D4CF-4358-A2F9-6DC1671E6512Q41864713-28987B96-A896-4B80-97F8-1A97C7839C9CQ42800694-CE7173C9-3708-4A83-818C-EE52BB7DD919Q43011229-B737B94A-1469-47A9-94A4-8DE7073E8115Q44009366-642DEB0A-2899-4345-B6B2-D14A883947C3Q44605515-69840404-8A65-45CA-858B-DFA1F417B442Q47990492-2ED366A3-FC27-4875-81F4-321E1A668842
P2860
Anaplastic large cell lymphoma: pathological, molecular and clinical features.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Anaplastic large cell lymphoma: pathological, molecular and clinical features.
@ast
Anaplastic large cell lymphoma: pathological, molecular and clinical features.
@en
Anaplastic large cell lymphoma: pathological, molecular and clinical features.
@nl
type
label
Anaplastic large cell lymphoma: pathological, molecular and clinical features.
@ast
Anaplastic large cell lymphoma: pathological, molecular and clinical features.
@en
Anaplastic large cell lymphoma: pathological, molecular and clinical features.
@nl
prefLabel
Anaplastic large cell lymphoma: pathological, molecular and clinical features.
@ast
Anaplastic large cell lymphoma: pathological, molecular and clinical features.
@en
Anaplastic large cell lymphoma: pathological, molecular and clinical features.
@nl
P2860
P1476
Anaplastic large cell lymphoma: pathological, molecular and clinical features
@en
P2093
P2860
P304
P356
10.1046/J.1365-2141.2001.02896.X
P407
P577
2001-09-01T00:00:00Z